<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02799290</url>
  </required_header>
  <id_info>
    <org_study_id>R15034</org_study_id>
    <nct_id>NCT02799290</nct_id>
  </id_info>
  <brief_title>Autologous Growth Factor Effect on Split-thickness Donor Site Healing: a Comparison of Adipose Tissue Extract and PRP</brief_title>
  <official_title>The Effect of Adipose Tissue Extract and PRP on Slpit-thickness Donor Site Wound Healing. A Comparative Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Tampere</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Tampere</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Adipose Tissue Extract (ATE) has been found to be an antologous source of growth factors with
      proven in vitro angiogenic and adipogenic properties.It is obtained by a simple
      lipoaspiration procedure. We sought to compare the effect of ATE with another known source,
      platelet-rich plasma to compare the wound healing characteristics on skin graft donor sites.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We enrolled 24 patients with and indication for skin graft. Two or more split-thickness
      grafts we taken per patient, one serving as control and the other as experimental. The
      experimenatl sites were covered with either autologous PRP or ATE prepared in the OR, which
      was selected in an unblinded manner due to surgical theater conveniece. However, donor sites
      were randomized through a computer generator. Covered with a semioclusive film, wound were
      separated and followed up on days 3,5,7,10,14 for wound healing and 30 and 60 for scar
      evaluation. Digital spectophotocutometry was applied to know the hemoglobin and melanin
      content of the wounds, and software was applied to know the rate of wound re-epithelization.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2015</start_date>
  <completion_date type="Actual">May 2016</completion_date>
  <primary_completion_date type="Actual">May 2016</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>wound re-epithelization</measure>
    <time_frame>30 days</time_frame>
    <description>observational-digital photogrpahy with specializaed custom-made software</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>scar properties</measure>
    <time_frame>60 days</time_frame>
    <description>Vancourver Manchester scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hemoglobin-melanin content</measure>
    <time_frame>60 days</time_frame>
    <description>spectophotocutometry measurements</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Wound Healing, Adipose Tissue Extract, Plateelt Rich Plasma, Skin Graft Donor Site</condition>
  <arm_group>
    <arm_group_label>CONTROL</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ADIPOSE TISSUE EXTRACT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Adipose Tissue extract application</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PLATELET-RICH PLASMA GEL</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PLATELET RICH PLASMA GEL APPLICATION</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>ADIPOSE TISSUE EXTRACT</intervention_name>
    <description>Adipose tissue extract is obtained on site with lipoaspirate adipose tissue prepared though incubation and filtration</description>
    <arm_group_label>ADIPOSE TISSUE EXTRACT</arm_group_label>
    <other_name>ATE</other_name>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>PLATELET-RICH PLASMA GEL</intervention_name>
    <description>Autologous platelet rich plasma is obtained onsite and activated following commercial kit instructions</description>
    <arm_group_label>PLATELET-RICH PLASMA GEL</arm_group_label>
    <other_name>PRP</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  donor site indication

        Exclusion Criteria:

          -  immunosupressive states

          -  terminal renal insufficiency

          -  pregnancy

          -  coagulation discrasias

          -  active infection in donor site
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Jenny Lopez, Ilkka Kaartinen</name>
      <address>
        <city>Tampere</city>
        <state>Pirkanmaa</state>
        <zip>33521</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <results_reference>
    <citation>Sarkanen JR, Kaila V, Mannerström B, Räty S, Kuokkanen H, Miettinen S, Ylikomi T. Human adipose tissue extract induces angiogenesis and adipogenesis in vitro. Tissue Eng Part A. 2012 Jan;18(1-2):17-25. doi: 10.1089/ten.TEA.2010.0712. Epub 2011 Oct 4.</citation>
    <PMID>21902602</PMID>
  </results_reference>
  <results_reference>
    <citation>Sarkanen JR, Ruusuvuori P, Kuokkanen H, Paavonen T, Ylikomi T. Bioactive acellular implant induces angiogenesis and adipogenesis and sustained soft tissue restoration in vivo. Tissue Eng Part A. 2012 Dec;18(23-24):2568-80. doi: 10.1089/ten.TEA.2011.0724. Epub 2012 Aug 17.</citation>
    <PMID>22738319</PMID>
  </results_reference>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 9, 2016</study_first_submitted>
  <study_first_submitted_qc>June 9, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 14, 2016</study_first_posted>
  <last_update_submitted>June 9, 2016</last_update_submitted>
  <last_update_submitted_qc>June 9, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 14, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Tampere</investigator_affiliation>
    <investigator_full_name>Jenny Lopez</investigator_full_name>
    <investigator_title>Medical Doctor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <pending_results>
    <submitted>October 26, 2016</submitted>
    <returned>December 22, 2016</returned>
    <submitted>May 1, 2017</submitted>
    <returned>August 4, 2017</returned>
    <submitted>September 5, 2017</submitted>
    <returned>March 30, 2018</returned>
    <submitted>April 24, 2018</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

